Uveal melanoma: From diagnosis to treatment and the science in between

C Chattopadhyay, DW Kim, DS Gombos, J Oba, Y Qin… - Cancer, 2016 - Wiley Online Library
Melanomas of the choroid, ciliary body, and iris of the eye are collectively known as uveal
melanomas. These cancers represent 5% of all melanoma diagnoses in the United States …

Metastatic tumors of the orbit and ocular adnexa

SM Ahmad, B Esmaeli - Current opinion in ophthalmology, 2007 - journals.lww.com
Breast carcinoma continues to account for the majority of metastatic lesions of the orbit and
ocular adnexa. Although the overall prognosis for patients with such lesions remains poor …

Sebaceous carcinoma: evidence-based clinical practice guidelines

JL Owen, N Kibbi, B Worley, RC Kelm, JV Wang… - The lancet …, 2019 - thelancet.com
Sebaceous carcinoma usually occurs in adults older than 60 years, on the eyelid, head and
neck, and trunk. In this Review, we present clinical care recommendations for sebaceous …

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel

NK Ibrahim, N Desai, S Legha, P Soon-Shiong… - Clinical cancer …, 2002 - AACR
Purpose: ABI-007 is a novel Cremophor-free, protein-stabilized, nanoparticle formulation of
paclitaxel. The absence of Cremophor EL may permit ABI-007 to be administered without …

[PDF][PDF] Integrative analysis identifies four molecular and clinical subsets in uveal melanoma

AG Robertson, J Shih, C Yau, EA Gibb, J Oba… - Cancer cell, 2017 - cell.com
Comprehensive multiplatform analysis of 80 uveal melanomas (UM) identifies four
molecularly distinct, clinically relevant subtypes: two associated with poor-prognosis …

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2–overexpressing metastatic breast cancer

FJ Esteva, V Valero, D Booser, LT Guerra… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the safety and efficacy of weekly docetaxel plus trastuzumab in
women with HER-2–overexpressing metastatic breast cancer. Efficacy was correlated with …

Visual outcome and ocular survival after penetrating trauma: a clinicopathologic study

B Esmaeli, SG Elner, MA Schork, VM Elner - Ophthalmology, 1995 - Elsevier
Purpose: Ocular trauma is a leading cause of blindness in the United States. This study was
undertaken to identify clinical and histopathologic factors that predict ocular survival and …

Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α

F Braiteh, C Boxrud, B Esmaeli, R Kurzrock - Blood, 2005 - ashpublications.org
Erdheim-Chester disease is a rare non-Langerhans histiocytosis with multisystem
involvement. To date, there is no standard treatment for this disorder, and more than half of …

Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner

JS Khalili, X Yu, J Wang, BC Hayes, MA Davies… - Clinical Cancer …, 2012 - AACR
Abstract Purpose: Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present
in approximately 80% of uveal melanomas. Mutant GNAQ/11 are not currently …

Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect

B Esmaeli, V Valero, MA Ahmadi, D Booser - Ophthalmology, 2001 - Elsevier
OBJECTIVE: To report a newly recognized side effect of a commonly used antineoplastic
agent, docetaxel, in three patients with metastatic breast cancer. DESIGN: Observational …